Same active ingredient as Ozempic, but at $147.90/month instead of $900+. Here's what the physician-prescribed personalized model means for safety, cost, and access.
HealthiCare Clinical & Editorial Team
Semaglutide is the active ingredient in Ozempic and Wegovy. That one fact changes the entire conversation about GLP-1 pricing - because it means the $900/month drug at the pharmacy and the $147.90/month option from a physician-prescribed telehealth program contain the same molecule. What differs is the manufacturing pathway, the regulatory status, and the pharmacy model behind each one.
Most patients researching this question already know semaglutide works. The clinical data is not in dispute. The STEP-1 trial showed an average of 15% body weight loss over 68 weeks. What they are actually trying to figure out is whether the affordable option is legitimate - and what makes it different from the brand-name version at a fraction of the cost.
At HealthiCare, we offer personalized semaglutide: a physician-prescribed, individually prepared prescription filled by a US-based, FDA-registered pharmacy. The active ingredient is the same. The price is $147.90 per month at every dose level - no escalation, no membership fee, no hidden costs. This article explains exactly how that is possible and what questions to ask before choosing any semaglutide program.
Yes - with one important distinction. Ozempic is a brand-name drug manufactured by Novo Nordisk that uses semaglutide as its active ingredient. Wegovy is the same active ingredient in a higher dose, approved specifically for weight management rather than type 2 diabetes. The drug itself - semaglutide - is not owned by Novo Nordisk. The brand name is.
This distinction matters because it explains how multiple legitimate pharmacy pathways can offer the same active ingredient at dramatically different price points. Brand-name drugs carry the cost of the FDA approval process - large-scale clinical trials, manufacturing facility audits, ongoing post-market surveillance, and patent protection built into the retail price. A physician-prescribed, individually prepared prescription filled by a licensed US pharmacy operates under a different regulatory pathway and a different cost structure. The active ingredient is the same. The development overhead behind it is not.
The molecule doing the work in both cases is semaglutide: a GLP-1 receptor agonist that slows gastric emptying, reduces appetite signals, and improves insulin sensitivity. The mechanism of action is identical because the active ingredient is identical.
Here is how the options actually compare for a cash-pay patient evaluating their choices.
The STEP-1 trial data applies to semaglutide - the molecule. The clinical evidence for how semaglutide works is not brand-specific. What the brand-name version has and the individually prepared version does not is a separate large-scale RCT conducted under the FDA's New Drug Application process. The active ingredient performing in that trial is the same active ingredient in a physician-prescribed personalized prescription.
Tirzepatide is a newer GLP-1 medication that also activates GIP receptors, producing a dual-mechanism action that delivers stronger average weight loss in clinical trials. Zepbound is the FDA-approved brand-name version for weight loss. Mounjaro is the same active ingredient approved for type 2 diabetes.
HealthiCare's personalized tirzepatide follows the same model as personalized semaglutide - same physician-prescribed, US-pharmacy-filled pathway, dramatically different price than the brand-name version. If you are weighing semaglutide vs tirzepatide as options rather than brand-name vs personalized, that decision depends on your health history and what your physician recommends. The semaglutide vs tirzepatide breakdown covers that comparison in detail.
The price of Ozempic and Wegovy reflects the cost of bringing a new drug through the FDA's full approval process - clinical trials across thousands of patients, manufacturing facility audits, post-market surveillance requirements, and the ongoing cost of patent protection. None of that is reflected in the active ingredient itself. Semaglutide as a molecule is not inherently expensive.
A licensed US pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act prepares medications based on individual patient prescriptions. This pharmacy model does not involve bulk manufacturing or the development costs behind a New Drug Application. It involves a physician writing a specific prescription for a specific patient, and a licensed pharmacist preparing that medication to fill it. That is a fundamentally different cost structure - and it is the reason the price difference is real and legally supported.
This is not a gray-market or unregulated pathway. The FDA has issued warnings specifically about overseas semaglutide sources and unverified online sellers. HealthiCare's pharmacy partner - F&F Pharmacies Inc. - is a US-based, FDA-registered 503A pharmacy with state board licensure and USP-compliant preparation standards. That is the difference between a safe, physician-supervised program and the sources the FDA is warning patients about.
The pharmacy source and prescribing model are the two variables that separate a legitimate program from the ones patients should avoid. Here is what to verify before starting any semaglutide program.
At HealthiCare, the prescribing process and the pharmacy are part of a single connected system. Here is the actual workflow.
You complete a brief online intake form. A board-certified physician through our Beluga Health clinical network reviews your health history and, if appropriate, writes a prescription tailored to your starting dose and titration plan. That prescription goes to F&F Pharmacies Inc., our US-based, FDA-registered pharmacy partner. Your medication ships directly to your door - 3-day delivery from intake to medication in most cases.
The pricing is fully itemized on our homepage. Personalized semaglutide at HealthiCare is $147.90 per month. That price does not change when your dose escalates. No membership fee. No price increase at month 3. Cancel anytime.
That pricing model is the core differentiator. Most programs start at a low dose price and increase as the titration schedule progresses - meaning the "starting from" price is not what most patients actually pay. HealthiCare has written 15,000+ GLP-1 prescriptions, and the price has held at every dose throughout. The 1.8M users in the Healthi App ecosystem - including 24 coaches and 20+ live weekly meetings - provide the behavioral support layer that a prescription alone cannot replace.
Both pathways are legitimate. The right choice depends on your insurance situation, your physician's recommendation, and what matters most to you clinically.
Personalized semaglutide through HealthiCare is typically the better fit if:
Brand-name Ozempic or Wegovy may be the better fit if:
Semaglutide is the active ingredient in Ozempic - not a different drug. Ozempic is the brand name Novo Nordisk uses for its semaglutide injection approved for type 2 diabetes. Wegovy is the same active ingredient at a higher dose, approved specifically for weight loss. A physician-prescribed personalized semaglutide prescription contains the same active ingredient through a different pharmacy pathway.
The price of Ozempic reflects the cost of FDA approval, large-scale manufacturing, and patent protection - not the cost of semaglutide itself. A US-based, FDA-registered pharmacy preparing an individually prescribed medication operates under a different cost structure. The active ingredient and the therapeutic mechanism are the same; the development overhead is not.
HealthiCare's personalized semaglutide is prescribed by board-certified physicians through Beluga Health and filled by F&F Pharmacies Inc. - a US-based, FDA-registered 503A pharmacy with state board licensure and LegitScript certification. This is a physician-supervised program using a US pharmacy, which is the meaningful distinction the FDA points to when warning patients about unsafe semaglutide sources.
Many patients make this switch. Both contain semaglutide as the active ingredient. Any change in medication source should be reviewed with a licensed physician who can evaluate your current dose and health history. HealthiCare's board-certified physicians can assess your situation through the standard intake process.
Brand-name Ozempic and Wegovy retail at $900 to $1,300+ per month without insurance. HealthiCare's personalized semaglutide is $147.90 per month at every dose level - the same price whether you are on the starting dose or a maintenance dose, with no membership fee and no escalation.
Yes. All semaglutide - brand-name or personalized - requires a prescription from a licensed physician. At HealthiCare, a board-certified physician through Beluga Health reviews your intake and writes a prescription tailored to your clinical profile. There is no prescription-by-questionnaire model here.
No FDA-approved generic version of semaglutide is currently available. Generic drugs must demonstrate bioequivalence to the brand-name version through an FDA-specific approval pathway. Personalized semaglutide from a 503A pharmacy is a different regulatory category - individually prepared under physician prescription, not a generic drug.
HealthiCare has written 15,000+ GLP-1 prescriptions through this model. If you are ready to see whether you qualify, the intake process takes a few minutes and a board-certified physician reviews your information typically within 24 hours.
See the full personalized semaglutide program details and start your intake - or explore the personalized tirzepatide program if tirzepatide may be a better fit. For a full breakdown of what GLP-1 programs cost across providers, the GLP-1 cost analysis covers the numbers in detail.
June 29, 2026
